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ABSTRACT
Toxoplasma gondii is a single-celled eukaryotic parasite that belongs to the
Apicomplexan phylum. Toxoplasma is an obligate intracellular parasite that is related to other
important pathogens, such as, Plasmodium, the causative agent of malaria. Toxoplasma can
reproduce both sexually and asexually and asexual reproduction is central to the pathogenesis of
this organism. Asexual reproduction consists of two developmental stages, the tachyzoites,
which grow rapidly and cause the acute infection and the bradyzoites, which grow slowly and
cause the chronic infection.
We are interested in identifying the genes involved in the bradyzoite differentiation
process in order to better understand the biology of the conversion between tachyzoites and
bradyzoites. To date, there are no drugs against the bradyzoite form, therefore, understanding
which genes are involved in the conversion could lead to improved drug therapies. In the
laboratory, we are able to induce the transition from tachyzoites to bradyzoites by starving the
parasites of carbon dioxide (CO2). This method of induction renders them unable to synthesize
pyrimidines, which stresses the parasites and causes them to switch to the dormant bradyzoite
form. Previous work in the Matrajt laboratory, using a forward genetic screen involving
insertional mutagenesis, generated several parasite mutants that are unable to switch from
tachyzoites to bradyzoites under CO2 starvation conditions.
In the current study, we performed whole genome-wide microarray analysis on 7
bradyzoite differentiation mutants and our data suggest that the mutant parasites are ‘stuck’ in an
intracellular state even when they are extracellular. This result suggests a commonality of
regulation for switching from state to state. We have also characterized functionally related gene
sets that are highly represented in the intracellular state and are able to identify genes that express
most differently across all mutant strains, as well as, between mutant strains and wild type.
Specifically, DNA replication genes are predominantly expressed during the intracellular state
compared to the extracellular tachyzoite or bradyzoite states. Interestingly, mutant extracellular
tachyzoites also express these DNA replication genes. Lastly, our data suggest a clear difference
between the gene expression profiles of wild type extracellular and intracellular parasites.
In addition to the microarray studies, we have characterized the disrupted locus in one of
the bradyzoite differentiation mutants, mutant B7. A putative non-coding RNA (ncRNA),
designated B41, has been physically disrupted in mutant B7 and its expression is developmentally
regulated in wild type but reduced in the mutant. B41 is a large, polyadenylated RNA that is
alternatively spliced (1kb and 2.2kb) and has no open reading frame. Two genes adjacent to the
insertion site, B41 and EST 13803210 have mis-regulated expression in mutant B7.
Overexpression studies of EST13803210 suggest that this EST does not play a key role in
bradyzoite differentiation. We also used luciferase reporter assays to test if the putative ncRNA,
B41, regulates the expression of EST 13803210 and it does not. Although we have been unable
to elucidate the function of B41, our results suggest that this gene is responsible for the mutant
phenotype since we were able to complement the mutant using a cosmid complementation system
that restored the mutant phenotype.
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CHAPTER 1: INTRODUCTION
1.1 General Biology of Toxoplasma gondii
Toxoplasma gondii is an obligate intracellular parasite that belongs to the phylum
Apicomplexa, which includes other important pathogens, such as Plasmodium (causes
malaria), Eimeria (causes poultry disease), and Cryptosporidium (causes gastrointestinal
disease). Most of the Toxoplasma isolates found in North America and Europe are
classified into three lineages; type I, type II and type III [1], and those not belonging to
these lineages are considered exotic strains. In the past, identification of parasite strain
type was performed by polymerase chain reaction- restriction fragment length
polymorphism (PCR-RFLP)[2] and microsatellite typing [3]. Recently, Dubey et al.,
2006, developed a novel and ingenious method for strain type determination based on
using 9 independent, non-linked genomic markers that enable the differentiation between
types I, II, and III in a single restriction enzyme digestion for each marker [1]. Although
each lineage is nearly identical at the DNA sequence level, there is great contrast in
virulence in mice [1]. Type I strains are highly virulent in mice with an LD100 = 1, while
type II and III strains are much less virulent with an LD100 > 103 [4].
Toxoplasma is a single-celled eukaryotic organism that has the typical organelles
found in other eukaryotes. In addition, it contains a unique set of apical organelles. The
apical organelles include secretory machinery: rhoptries, micronemes and dense granules,
and a plastid called the apicoplast.
The rhoptry is a club-shaped organelle that contains two types of proteins, rhoptry
proteins (ROPs) and rhoptry neck proteins (RONs), plus lipid. The lipid content is made
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up of cholesterol and phospholipids and is responsible for the 'membrane swirls' seen in
electron micrographs [5]. ROPs localize to the bulbous region of the rhoptries and the
RONs localize to the neck region of this organelle [5]. Interestingly, these two types of
proteins are separated in space within the rhoptry although there is no evidence of a
physical barrier between the two regions [5]. It is well established that rhoptry proteins
are secreted during invasion. It is known that RONs 2, 4, and 5 form a complex with the
microneme protein, AMA1, to structure/shape the moving junction [6, 7]. The moving
junction forms a ring-shaped complex between the anterior boundary of the parasite and
the host cell plasma membrane and is used by the parasite to pull itself into its host cell
[5]. ROPs are known to localize to three different sites after secretion: (1) the lumen of
the parasitophorous vacuole, (2) the parasitophorous vacuole membrane, or (3) the
interior of the host cell [5].
Micronemes are small, cigar-shaped secretory organelles that are also involved in
the process of invasion. The number of microneme organelles per parasite depends on
the species and the developmental stage [8]. When a parasite is hunting for a host cell to
invade, it touches its host cell and calcium is released from stores within the parasite.
This release in calcium triggers secretion of microneme proteins into the junction
between the parasite and the host and this event allows adherence of the parasite to the
host cell [9-11]. It is interesting to note that the products of the secretory organelles work
together to accomplish biological processes such as invasion. As described above, a
microneme protein (AMA1) interacts with rhoptry proeins (RONs) to facilitate adhering
and invading the host cell.
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The dense granules are spherical organelles that contain a high concentration of
proteins as suggested by the overall density observed under a transmission electron
microscope [8]. In contrast to the rhoptries and micronemes, the dense granules are
localized throughout the parasite, secrete laterally (in contrast to apical secretion), and are
involved in modifying the structure of the parasitophorous vacuole for the developing
parasite [8]. It is not fully understood whether secretion from dense granules is
constitutive or regulated, as there is evidence for both mechanisms. It is possible that
secretion is triggered in both fashions; constitutive release enhanced by the ADPribosylation factor-1 (ARF-1) [12] and regulated release that occurs shortly after invasion
and results in a massive discharge of protein into the parasitophorous vacuole [13].
The apicoplast is a chloroplast-like plastid that is unique to the Apicomplexa
phylum and originated from a secondary endosymbiotic event (Figure 1).
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Figure 1. "A scheme for the origin and evolution of all plastids by primary and
secondary endosymbiosis.” TRENDS in Genetics Vol.18No.11 Nov. 2002 [14].
Details of the secondary endosymbiotic event that occurred in Toxoplasma gondii is discussed in
the text.

4

Back in evolutionary time, a heterotrophic eukaryote engulfed a photosynthetic algal cell
[15]. Instead of digesting the algal cell, the eukaryote adopted it as a symbiont. The
secondary endosymbiotic event occurred when a common ancestor to Toxoplasma and
other Apicomplexans engulfed the (previously mentioned) heterotrophic eukaryote [15].
The apicoplast is surrounded by four concentric membranes, which are the
products of the primary and secondary endosymbiotic events. The two inner membranes
are the remnants of the inner and outer membranes of the algal chloroplast. The third
membrane that surrounds the two inner membranes represents the algal plasma
membrane. The outer membrane of the apicoplast is the vacuole membrane that was
formed during the engulfment which resulted in the secondary endosymbiosis [15]. The
apicoplast contains a 35kb circular DNA genome that has many chloroplast-like features
including open reading frames with homology to RNA polymerases found in eubacteria,
ribosomal proteins and rRNAs [16]. Interestingly, some of the molecules that localize to
the apicoplast have proved to be successful drug targets in other systems, thus the
apicoplast, not a part of mammalian cells, is a promising target for parasiticidal drugs
against Toxoplasma gondii [15].
1.2 The life cycle of Toxoplasma gondii.
Toxoplasma gondii reproduces both sexually and asexually (Figure 2).

5

Figure 2. The life cycle of Toxoplasma gondii.
The details of the Toxoplamsa gondii life cycle are discussed in the text.

Sexual reproduction only occurs in the cat and begins when a cat ingests infectious
oocysts or an animal that is infected with bradyzoite tissue cysts (Bogtish and Cheng
1998). The tissue cysts are resilient and are able to pass through the gastric fluids of the
stomach unharmed. They travel to the intestine where the bradyzoites are released from
their resident cysts and infect intestinal cells, entering into the enteric phase of the sexual
cycle. The bradyzoites switch to tachyzoites and go through several rounds of
6

replication, then switch back to bradyzoites where they form macrogametes and
microgametes, which fuse to form an oocyst. Oocysts are released in cat feces and the
sporozoites within the oocyst become infectious within a couple of days of maturation.
The infectious sporozoites can then infect a variety of intermediate hosts, including; deer,
sheep, cattle, humans, etc. (Bogtish and Cheng 1998). Toxoplasma gondii has the ability
to infect all nucleated mammalian cells studied to date and this is where asexual
reproduction occurs. Humans may eat raw or undercooked meat that contains bradyzoite
cysts or may become infected from infectious sporozoites that have been released into an
infected cat’s litter box. Once an individual is infected with Toxoplasma gondii the
parasites differentiate into fast-growing tachyzoites and disseminate throughout the body
via macrophages. In an immunocompetent individual, tachyzoites are eliminated by host
immune responses within 7-10 days but tissue cysts containing the slow growing
bradyzoites persist (because they are immunoprivileged) and are responsible for the
chronic infection [17]. Several stress methods for inducing bradyzoite formation in vitro
have been developed, including CO2 starvation, high pH, electron transport inhibitors and
temperature stress [17].
When the asexual cycle of Toxoplasma gondii is thought of in the context of
cellular states, we acknowledge a two state switching mechanism consisting of the
tachyzoite and bradyzoite end states. Extracellular tachyzoites invade host cells and
replicate until they lyse the host cell. But, if the intracellular state parasites sense a
stressful environment, presumably via a host signal, then they will transition to the
bradyzoite end state. Likewise, if the bradyzoite state parasites sense a release of the
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stress signal, they will transition back to the tachyzoite state, which after rapid replication
and egress, will transition to an extracellular tachyzoite state. The chronic infection
poses a serious threat to immunocompromised individuals because once the immune
system becomes repressed the bradyzoites can reactivate into tachyzoites and cause
severe disease. Given this information, it is clear that the asexual cycle is central to the
pathogenesis of Toxoplasma gondii.
1.3 Epidemiology and Risk Factors
Toxoplasma infection is one of the most common opportunistic diseases in the
world today (http://www.cdc.gov/toxoplasmosis/epi.html). In the United States, ~22% of
the population is infected while the prevalence reaches > 95% in other areas of the world
(http://www.cdc.gov/toxoplasmosis/epi.html). Infection rates are highest in low altitude
areas where the climate is very hot and humid
(http://www.cdc.gov/toxoplasmosis/epi.html). Infection with Toxoplasma can occur
from eating raw or undercooked meat containing tissue cysts or through accidental
ingestion of infectious sporozoites that have been released from cat feces. In rare
instances, infection occurs through blood transfusions and organ transplants
(http://www.cdc.gov/toxoplasmosis/epi.html). Toxoplasmosis causes severe disease in
immunocompromised patients (AIDS patients, patients on chemotherapy, etc.) and can
cause neurological disorders to the fetus if the mother becomes infected during pregnancy
[17].
Treatment of toxoplasmosis in immunocompetent individuals does not usually
occur since the infection is generally asymptomatic in these patients. However, women
8

who are pregnant and have never been infected with Toxoplasma might be treated with
the drug Spiramycin to prevent infection of the placenta [18]. Spiramycin is not available
throughout the world. In fact, it is currently unavailable in the United States because it
has not yet been approved by the USFDA [18]. Pyrimethamine and Sulfadiazine are
commonly used to treat Toxoplasma infection unless the patient is allergic to sulfa drugs,
in which case, that patient would be treated with Clindamycin [18]. Recently, a “golden
bullet” drug strategy has been developed, where antibodies against tachyzoites are
attached to gold nanorods and injected into the host [19]. The gold nanorods bind to
Toxoplasma and then a laser is used to heat up and kill those parasites that are bound to
the nanoparticles. This method has not been tested in human patients yet, but proves to
be another promising drug against toxoplasmosis.
Although the currently available drug therapies are useful in some situations, they
are not ideal. The major threat of Toxoplasma gondii infection is reactivation of the
dormant bradyzoites during a chronic infection. An ideal drug would either kill the
bradyzoite form (during a chronic infection) or block formation of the bradyzoite form
(preventative medicine) of the parasite so that this threat is eliminated. Additionally,
therapy that blocks the bradyzoite to tachyzoite transition would also protect the patient
against reactivation during chronic disease.
1.4 Bradyzoite Differentiation
During the conversion of tachyzoites to bradyzoites: replication rate decreases,
differential gene expression occurs and there is a major reorganization of organelles.
Tachyzoites and bradyzoites replicate by endodyogeny and endopolygeny [20].
9

Endodyogeny replication is synchronous and consists of the mother parasite producing
two identical daughter parasites that engulf the mother. Endopolygeny, also called
schizogeny, occurs asynchronously and involves the mother parasite developing into
several identical daughter parasites before cytokenesis. In general, tachyzoites
reproduce by endodyogeny with a doubling time of ~7 hours [21, 22], but do reproduce
by endopolygeny ~0.5-5% of the time [23]. Bradyzoites mostly replicate by
endodyogeny with a doubling time of >12 hours but endopolygeny is observed in 16%
(24h post induction) - 50% (48h post induction) of parasites as evidenced by positive
Dolichos lectin (marker of expression of the cyst wall protein, CST1) staining of the cyst
wall of these slow, replicating bradyzoites [20]. It is also well established that the timing
of differentiation varies from vacuole to vacuole [20].
Several groups have studied gene expression patterns during the tachyzoite to
bradyzoite transition process, observing both wild type and bradyzoite differentiation
mutant parasite lines. It is important to note that each study has used different parasite
strains (predominantly, type I or II), different bradyzoite induction conditions
(predominantly, CO2 starvation or alkaline (pH 8.1) conditions), and analyzed varying
time points before and after induction [24, 25]. This information is a crucial
consideration to have when comparing results across different studies. In spite of these
important differences, the overall biology of the transition is similar in each study.
Before whole genome microarray chips were available, researchers generated Expressed
Sequence Tag (EST) libraries and compared EST abundance between stages [25], and
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generated cDNA microarrays [24] to study the gene expression profiles during
conversion.
Serial analysis of gene expression (SAGE) is another molecular tool for
quantifying gene expression levels for both known and unknown transcripts. In brief,
total RNA is incubated with oligo dT-bound magnetic beads and polyadenylated
messengerRNA (mRNA) is captured by the dT oligomers. The RNA is copied into
complementary DNA (cDNA) which results in beads that contain the original oligo dT
primer bound to cDNA that is a copy of the original mRNA. Next, the 5’ end of the
cDNA is cleaved leaving a ‘sticky’ end for a ‘docking’ molecule to attach. A specialized
enzyme binds to the docking molecule and cuts off a short segment of the cDNA
molecule. This results in a collection of short tags that represent each mRNA molecule
represented in the original total RNA sample. Each tag has the ability to bind to the end
of other tags leading to the formation of a DNA tag concatemer, which is then amplified
into millions of copies for analysis. Finally, computer analysis counts each tag, assigns
each tag to its cognate mRNA molecule, and tells the researcher which tags came from
known genes and which tags represent new genes (http://www.emblheidelberg.de/info/sage/). This method gives us a global view of the expression levels of
every transcribed gene in a given sample.
Genes that are most differentially expressed between tachyzoites and bradyzoites
are encoded into proteins that fall primarily into three functional groups: (1) stagespecific surface proteins, (2) regulatory and metabolic enzymes, and (3) secretory
proteins. One important difference between tachyzoites and bradyzoites is the variety of
11

surface proteins that are expressed in a stage-specific manner [25]. Three SAG1 related
surface antigens are highly expressed in bradyzoites compared to tachyzoites; SRS9
(Ctoxoqual contig 4130) [24], SAG2C/D (Ctoxoqual contig 4135), and BSR4 [24]. Two
other genes, (cyst matrix antigen) MAG1 and a mucin domain-containing (Ctoxoqual
contig 3897), are expressed in tachyzoites but expression is significantly increased under
bradyzoite conditions [24]. MAG1 encodes a cyst matrix antigen and the mucin domaincontaining protein may provide a protective barrier for bradyzoite cysts against the
degradative enzymes within the gut due to the property that mucin domains are highly
glycosylated [24]. The mucin domain-containing protein may also play a role in
bradyzoite invasion since its homologue in the Apicomplexan, Cryptosporidium parvum,
in known to be involved in host cell invasion [26].
There are three regulatory enzymes involved in metabolism that are highly
upregulated in bradyzoites; methionine aminopeptidase (MAP) (Ctoxoqual contig 4080),
oligopeptidase (Ctoxoqual contig 1284), and a gene that encodes a protein that has
homology to class II pyridoxal phosphate-dependent aminotransferases (Ctoxoqual contig
4095) [24]. MAP may regulate protein synthesis during the tachyzoite to bradyzoite
transition by cleaving the N-terminal methionine of nascent proteins and may also be
involved in inhibiting the phosphorylation of the initiation factor 2a as seen in other
eukaryotes [27]. The oligopeptidase may be involved in regulating bradyzoite-specific
metabolic pathways much like bacterial oligopeptidases regulate lactose metabolism [28].
It is known that class II pyridoxal phosphate-dependent aminotransferases are involved in
many cellular processes including amino acid metabolism and sphingolipid synthesis [29]
12

and may be important in establishing and/or maintaining the bradyzoite cyst environment.
In contrast, glucose-6-phosphate dehydrogenase (G6PD) (Ctoxoqual contig1694) is
highly expressed in tachyzoites but is repressed in bradyzoites. G6PD is an enzyme
involved in initiating the pentose phosphate shunt which could represent an important
regulatory mechanism for differences observed in sugar metabolism in tachyzoites
compared to bradyzoites [24]. Also, a decrease in G6PD causes a shift in metabolism to
gluconeogenesis and, thus, amylopectin synthesis [24] and consistent with this
amylopectin granules can be visualized ~75 hours post bradyzoite induction [25].
Lastly, some of the genes that encode proteins that localize to the specialized
secretory organelles in Toxoplasma gondii are also transcriptionally regulated during
stage conversion. For example, nucleoside triphosphate hydrolase 1 (NTP1) (Ctoxoqual
contig 4801) [30], and genes encoding dense granule proteins, GRA1 (Ctoxoqual contig
619) and GRA5 (Ctoxoqual contig 1406), and the gene encoding the rhoptry protein,
ROP1 (Ctoxoqual contig 20), are all repressed in bradyzoites compared to tachyzoites
[24]. In their 2002 manuscript, Boothroyd et al., stated that “Genes whose transcript
levels increase in bradyzoites represent promising targets for a reverse genetics approach
to identifying genes essential for bradyzoite development through targeted disruption.”
[24]. In our laboratory, we have performed whole genome microarray analysis for a time
course in bradyzoite differentiation and have identified hundreds of genes (n = 788)
whose transcript levels increase in bradyzoites (72h post induction) and therefore
represent potential targets for reverse genetic studies in the future (unpublished data, P.
Lescault).
13

The process of bradyzoite differentiation involves regulation of the cell cycle rate,
alteration of gene expression and reorganization of organelles. During the transition, the
nucleus relocates from a central position in tachyzoites to a posterior position in
bradyzoites [31]. Whether or not the mitochondrion is active in bradyzoites is debatable
since bradyzoites are widely considered to be the dormant form [32, 33]. Roos et al.
2004, showed that the mitochondrion and endoplasmic reticulum have decreased activity
in bradyzoites compared to tachyzoites but the architecture is unchanged [20]. They also
showed that protein activity within the dense granules is higher in tachyzoites compared
to bradyzoites. However, in bradyzoites, dense granule proteins are secreted into the
parasitophorous vacuole. The micronemes are restricted to the apical end of the
tachyzoites but are dispersed throughout the body of the bradyzoite [20]. Roos et al.,
2004, found no architectural differences in the rhoptries during differentiation [20].
Amylopectin granules are found in bradyzoites (75 h post induction) and this observation
indicates the changes in energy metabolism during conversion [20]. Interestingly, the
apicoplast seems to disappear in mature bradyzoites over time (35-124 hours) [20]. Time
lapse microscopy studies revealed three different mechanisms for the loss of the
apicoplast: (1) failure of the apicoplast to divide during endodyogeny, remaining in the
residual body and resulting in two daughters without an apicoplast, (2) only one daughter
received the apicoplast, and (3) the apicoplast seemed to degenerate in the absence of
division as evidenced by loss of DAPI staining [20]. Lastly, although bradyzoites show a
clear decrease in cell growth compared to tachyzoites, they are remarkably motile. They
are able to escape the parasitophorous vacuole and invade an adjacent host cell without
14

disturbing the host cell. This phenomenon is in stark contrast to the tachyzoites, which
lyse the host cell rendering it dead. Bradyzoites accomplish escape and reinvasion
without switching to the tachyzoite form. This unique bradyzoite-specific mechanism
may be what allows them to form many tissue cysts with just one infection [20]
1.5 Mutant screen and Preliminary Data
Matrajt et al. 2002, developed a genetic screen to isolate parasites unable to form
bradyzoites in order to identify key genetic factors that are involved in the bradyzoite
differentiation process (Figure 3) [34].
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Figure 3. Strategy for isolating bradyzoite differentiation mutants.
“A. Construction of the parental parasite line 7-1, harbouring a combined positive/negative
selectable marker (HXGPRT) that is specifically induced under bradyzoite differentiation
conditions.B. Selection strategy used to isolate parasites harbouring regulatory gene mutations.
This study reports on the isolation of putative mutants defective in positive regulation of
bradyzoite gene expression. HXGPRT OFF indicates resistance to 6-thioxhantine (6-TX) and
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sensitivity to mycophenolic acid (MPA); HXGPRT ON is 6-TXS and MPAR.C. Strategy for the
identification of bradyzoite differentiation mutants by insertional mutagenesis.” [34]

First, a vector containing the selectable marker, hypoxanthine xanthine guanine
phosphoribosyltransferase (HXGPRT), was placed under the control of a strong
bradyzoite-specific promoter (pt7) (Unpublished promoter trap data, R. Donald and D.
Roos). HXGPRT is a purine salvage enzyme that is resistant to mycophenolic acid
(MPA) but susceptible to 6-thioxanthine [35]. RH ΔHXGPRT/ΔUPRT, a type I strain,
was used because inactivation of the HXGPRT gene made this strain appropriate for
selection in the mutant screen and the UPRT deletion makes this strain sensitive to
pyrmidine starvation under low CO2 conditions which allows for efficient induction of
the tachyzoite to bradyzoite transition in vitro [36-38]. After transfection with the pt7HXGPRT vector, parasites were selected for MPA resistance under bradyzoite induction
conditions (CO2 starvation) and 6-thioxanthine resistance under tachyzoite conditions
(high CO2) resulting in the 7-1 parental parasite line (Figure 3A).
The rationale behind this screen was if mutagenesis of the parental line knocked
out a positive regulator of bradyzoite formation, then the selectable marker, HXGPRT,
would not be expressed and the drug 6-thioxanthine would kill all parasites that do
express HXGPRT, therefore isolating only those parasites that have a positive regulator
knocked out (Figure 3B). Likewise, if the mutagenesis resulted in knocking out a
negative regulator of bradyzoite formation then the HXGPRT would be expressed under
both tachyzoite and bradyzoite conditions, but this study focused on positive regulator
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knockouts. MPA would be used to select for only those parasites that do not express
HXGPRT.
Next, insertional mutagenesis was performed with a mutagenesis vector that
confers resistance to prymethamine [37, 38]. Transfected parasites were treated with
prymethamine to kill all parasites that did not receive the mutagenesis vector. After host
cell lysis, tachyzoites were inoculated onto a fresh monolayer of host cells (human
foreskin fibroblasts) and placed under CO2 starvation conditions. In order to isolate
mutant parasites that were unable to switch to form bradyzoites, cultures were treated
with prymethamine and 6-thioxanthine for 3 days. Again, pyrmethamine treatment killed
all parasites that did not receive the mutagenesis vector and 6-thioxanthine selected for
parasites that did not express HXGPRT under bradyzoite conditions. The parasites were
then put under tachyzoite conditions to grow up the populations and this selection
strategy was repeated 3 more times to enrich the populations (Figure 3C).
Two mutant parasites were generated in this initial screen, B7 and P11.
Experimental assays showed that these mutants had growth defects under bradyzoite
conditions. They grew fast, similar to wild type tachyzoites, under bradyzoite conditions.
Expression of HXGPRT and two known bradyzoite-specific markers (BAG1 and
Dolichos lectin) were quantified in the mutant parasites under bradyzoite conditions (CO2
starvation and alkaline conditions). Mutants showed reduced expression of these two
bradyzoite markers. These results showed that the mutants, B7 and P11, are indeed
bradyzoite differentiation mutants; they grow fast under bradyzoite conditions and have
reduced expression of bradyzoite-specific markers under two different induction
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conditions. It was important to look at two known bradyzoite-specific markers in
addition to HXGPRT expression because it was possible that the mutants were only
deficient in HXGPRT expression, which is not the case. It was also important to test
whether the mutant phenotype was specific for CO2 starvation conditions or if it was a
more general effect. Since these mutants are defective in forming bradyzoites under an
additional induction condition, alkaline conditions (not used to generate the mutants), the
mutants must have a more general defect in bradyzoite formation.
After this initial study, several additional bradyzoite differentiation mutants were
generated (Figure 4) (unpublished data, B. Thompson).

Figure 4. Seven bradyzoite differentiation mutants have been disrupted in distinct
sites in the genome.
The chromosome and position of the insertion site is shown for each mutant. Annotation of the
physically disrupted gene (or the gene closest to the insertion site) is shown. **position 4328500
for mutant 11P is a near approximation and is currently being confirmed.

Since two features that distinguish bradyzoites from tachyzoites are (1) their difference in
replication rates and (2) their differential gene expression, all mutants were assayed for
replication rate and expression of bradyzoite-specific markers. Replication rate was
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assayed at 72h post induction and the number of parasites per vacuole was counted for all
samples. All seven mutants show an increase in replication rate compared to wild type
after 72h of bradyzoite induction (unpublished data not shown, V. Patil).
Expression of two known bradyzoite-specific markers (BAG1 and Dolichos
lectin) was measured in wild type and mutant parasites after 72h of bradyzoite induction
(unpublished data, V. Patil) (Figure 5).

Figure 5. Expression of bradyzoite-specific markers, BAG1 and Dolichos lectin, in
wild type and mutants parasites after 72h of bradyzoite induction.
Wild type (71) show differential expression of the two bradyzoite-specific markers. Percentage
of vacuoles that stained positive for the markers was measured. BAG1 expression is shown in
green and Dolichos lectin staining is shown in red.

BAG1 is a major cytosolic antigen and Dolichos lectin binds to the cyst wall.
Approximately 80% of wild type parasites induced expression of these bradyzoitespecific markers, whereas the mutants showed significantly reduced expression.
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However, 20-30% of mutant parasites do express these bradyzoite-specific markers
indicating a degree of leakiness of the mutant phenotype (a small percentage of parasites
in each mutant parasite line have the ability to form bradyzoites).
1.6 The Affymetrix Toxoplasma gondii GeneChip
The ToxoGeneChip was designed such that a variety of expression analyses
(whole genome, transcript discovery, alternative splicing, genotyping, etc.) could be
achieved on a single chip and this ingenious design came from the efforts of A. Bahl,
under the direction of D. Roos. (This was a remarkable design, worthy of noting,
especially when you consider that most microarray chips available today only allow for
one type of analysis per microarray chip.) Affymetrix manufactured the ToxoGeneChip
by using photolithographic technology, which allows for the simultaneous production of
millions of probes on one chip
(http://www.affymetrix.com/technology/manufacturing/index.affx) (Figure 6).
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Figure 6. Photolithographic design used to create the ToxoGene chip.
The details of this technology are discussed in the text.

In brief, a square quartz wafer (5” X 5”) is coated with a light sensitive chemical
compound and then a mask is applied to the wafer. Next, the wafer is subjected to light,
which deprotects the spots that are exposed by the mask and a nucleotide solution
containing adenine, thymine, cytosine, or guanine is added. In the example above
(Figure 6), a solution of thymine is added and will only couple with the hydroxyl groups
that remain exposed by the mask. The probes are 25 nucleotides (nt) in length, so this
process is repeated 25 times. Approximately 100 masks are required to produce one
quartz wafer containing millions of 25 nt probes since each nucleotide addition requires 4
masks (one for each of the 4 nucleotide solutions). Once this process is completed, the 5”
X 5” quartz wafer is cut up into several hundred individual microarray GeneChips
(http://www.affymetrix.com/technology/manufacturing/index.affx).
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The ToxoGeneChip contains a total of 214,042 probes (97% of the chip), which
include the following: ~49% for whole genome expression profiling, ~33% for
transcript/SNP discovery, ~10% for genotyping (genetic markers, resequencing SNPs and
EST based SNPs), ~5% controls (human, mouse, yeast, cat genes), 0.64% for apicoplast
genes, and 0.11% for mitochondrial genes (ToxoDB). For whole genome expression
profiling, there are ~ 11 matched probes to each of ~8000 predicted genes in the
Toxoplasma gondii genome and each probe alignment can be viewed in the genome
browser section of ToxoDB (http://www.toxodb.org/toxo/home.jsp) (Figure 7).

Figure 7. An example of the 11 probes aligned to a gene in the ToxoDB.
This example shows the exact position of each of the 11 probes that are aligned to gene,
49.m00018, as seen in ToxoDB.

1.7 Summary of Main Results
Two important studies of the bradyzoite differentiation mutants will be discussed
in this thesis: (1) the whole genome expression microarray analysis of seven bradyzoite
differentiation mutants and (2) the characterization of the disrupted locus in mutant B7.
23

In the microarray analysis study we describe 4 main results: (1) the expression
profile of wild type parasites after 24h of induction (intracellular state) is different from
the expression profile of wild type extracellular tachyzoites; (2) Mutant extracellular
tachyzoites (5/7) show a different expression profile compared to wild type extracellular
tachyzoites, while 2/7 mutant extracellular tachyzoites show similar expression to wild
type extracellular tachyzoites; (3) after 72h of induction, mutant parasites show a similar
expression profile to wild type 24h post induction; and (4) we have developed a method
for identifying genes that differ most in expression levels across all samples.
Characterization of the disrupted locus in mutant B7 revealed 5 main
observations; (1) a putative ncRNA (B41) was disrupted and its expression is
developmentally regulated in wild type parasites but expression is reduced in mutant B7,
(2) the expression of an adjacent EST 13803210 is affected in the mutant but
overexpression experiments show that this EST is not a key player in the bradyzoite
differentiation pathway, (3) luciferase assays show that B41 does not function in
regulating the expression of EST 13803210, (4) B41 is alternatively polyadenylated into
a short (1kb) and a large (2.2kb) transcript and (5) cosmid complementation of mutant B7
restored the phenotype.

24

CHAPTER 2: MICROARRAY ANALYSIS: DISSECTING THE EXPRESSION
PROFILES OF BRADYZOITE DIFFERENTIATION MUTANTS IN
TOXOPLASMA GONDII
Abstract
The goal of our research is to identify genes involved in the regulation of the
tachyzoite to bradyzoite interconversion because the proteins encoded by these genes
may serve as potential drug targets that could prevent bradyzoite formation or rid the host
of a chronic infection. As described in Chapter 1, the Matrajt laboratory used a genetic
screen to isolate seven mutants that show defects in bradyzoite formation; increased
replication rate and reduced expression of bradyzoite-specific markers under bradyzoite
induction conditions. I have focused this branch of my research on dissecting the
expression profiles of these mutants using whole genome microarray analysis. Each gene
expression profile appears to fit, at a coarse level, into one of three states, which we name
based on wild type samples harvested at times 0, 24, and 72 hours after bradyzoite
induction: extracellular tachyzoites (WT0), intracellular low CO2 parasites (WT24), and
bradyzoites (WT72). We show that under tachyzoite growth conditions, extracellular
mutant parasites (t = 0h) exhibit a significantly different expression profile from wild
type, WT0 (t = 0h) (p < 0.001). However, extracellular mutant parasites (t = 0h and 72h)
show a strikingly similar expression profile to WT24 (p < 0.02). These results suggest
that the mutant parasites are ‘stuck’ in a WT24-like (intracellular) state even when they
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are extracellular and that there may be a commonality of regulation when switching from
state to state. Lastly, we have developed a method to identify genes that differ most in
expression levels across all samples, which may allow us to order the mutants along the
bradyzoite induction pathway, as well as provide candidate target genes for further
studies on bradyzoite differentiation.
2.1 Introduction: Microarray Analysis
2.1.1 Experimental Design.
The whole genome microarray experiment was designed to evaluate the
expression profiles of mutant and wild type parasites under tachyzoite and bradyzoite
induction conditions in order to better understand how the disrupted loci in the mutants
affect bradyzoite formation. Freshly egressed extracellular tachyzoites were harvested
for the tachyzoite samples (t = 0h) and parasites subjected to bradyzoite induction
conditions for 72h were harvested for the bradyzoite samples (t =72h). At the time of the
experimental design it was assumed that there were little to no differences between
extracellular and intracellular tachyzoites, therefore extracellular tachyzoites were used as
the tachyzoite sample in order to avoid host cell contamination during the sample
preparation (personal communication from M. Matrajt and D. Roos). (Toxoplasma
gondii is an obligate intracellular parasite, therefore host cell RNA contamination of
parasite RNA samples is an important concern and the details of how we addressed this
concern in the current study will be discussed in the last chapter).
When we originally compared the expression profiles of mutants and wild type,
we were surprised to find that there were hundreds of genes in the mutants that behaved
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similarly to wild type. We expected that most genes in the mutants would not respond to
bradyzoite induction conditions and that a few genes would respond similar to wild type.
If this were the case then we would be able to identify that a particular mutant was
blocked in the bradyzoite differentiation pathway just upstream from the responsive
genes (Figure 8).

Figure 8. Differential gene expression plots show an example of what we expected to
observe (left) compared to what we actually observed (right top-Mutant 13P; right
bottom-Mutant B7).
Wild type differential gene expression (under bradyzoite conditions compared to under tachyzoite
conditions) is shown on the x-axes and mutant differential gene expression is shown on the yaxes. Details of the significance of this figure are discussed in the text.
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Since we did not observe the expected scenario, we had to apply additional methods for
analysis and these will be discussed in the Results section.
During our preliminary analysis, we contemplated the idea that these mutants may
be delayed in forming bradyzoites and if we were able to lengthen the induction time then
we may see bradyzoite formation of the mutants. Because it was technically impossible
to lengthen the induction time much past 72h due to host cell stress and death, we chose
to do microarray analysis on a time course to address this hypothesis. We performed a
bradyzoite induction time course with wild type parasites only and harvested at 24h, 36h
and 48h post-induction. (If the mutants were delayed in forming bradyzoites then we
might have observed that the expression profile for a mutant after 72h induction may be
similar to the expression profile of the wild type after only 24h of induction and this was
not the case.) An overview of the entire experimental design is illustrated below (Figure
9).

Figure 9. A schematic of the experimental design for the microarray experiments.
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Caveat lector. For simplicity and clarity throughout this thesis, we will refer to our 24h
time point as “intracellular low CO2 parasites”, in order to account for the fact that we
cultured these parasites under bradyzoite induction conditions but their expression profile
matches to a great extent to ‘true’ intracellular tachyzoites (cultured under tachyzoite
growth conditions, ie., high CO2) (unpublished data, D. Roos and A. Bahl, and analysis
of data shown in section 4.1, J. Bond and P. Lescault). Because our experimental design
dictated that we use freshly egressed extracellular tachyzoites as time 0h rather than
intracellular tachyzoites 24h post invasion, we have missed important biological events
(host cell invasion, intracellular replication as tachyzoites before sensing the signal to
switch to bradyzoites, etc.) and, thus, gene induction patterns along the differentiation
pathway in our time course (Figure 10).
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Figure 10. Using extracellular tachyzoites as time 0h in our bradyzoite induction
time course prevented observation of important gene expression changes between 0h
and 24h resulting in the 24h sample showing a combination of the gene expression
changes.
Using intracellular tachyzoites (D. Roos laboratory experimental design) allows for observation
of intracellular tachyzoite state (0h), early bradyzoite state (exclusively), and bradyzoite state
gene patterns. In contrast, using extracellular tachyzoites as time 0h prevented the observation
that there is a distinction between genes represented by the intracellular tachyzoite (24h) and
early bradyzoite states (24h), instead, the 24h point shows a combination of these two states.
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We have designed a new experiment to address this issue (results pending) and the details
of this new experimental design will be discussed in the last chapter. For the remainder
of the thesis, we will refer to the 24h time point (WT24) as “intracellular low CO2
parasites”.
2.1.2 Expression statistics (E) relate to intensity (I)

Iij ∝ RNAij
The intensity for probe set, i, of sample, j, is proportional to the RNA
concentration for probe set, i, of sample, j (Figure 11).

Figure 11. A schematic of the details of how expression statistics relate to intensity.
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In brief, total RNA is extracted from the parasite sample and reverse transcribed into
cDNA. Next, the cDNA is in vitro transcribed into cRNA and then the cRNA is
fragmented and hybridized to the affymetrix ToxoGeneChip. A pixeled image of the
hybridized chip is produced and probe intensities for each set of pixels is calculated using
a statistical algorithm software program. Next, the background is adjusted and a quantile
normalization and summarization of the probe intensities is performed in order to
produce the probe set intensity.

I : i ⊗ j |→ [0,∞]
The intensity for a given probe set (I) is based on probe set, i, of sample, j, and is inferred
to be a positive value between zero and infinity. A normalization step at this point in the
analysis includes a background correction and a scaling correction and is important for
accounting for two types of potential errors. Background correction will account for chip
to chip variation where,

Iij = Iik + Δjk
j and k represent two different microarray chips and delta accounts for the differences in
the properties of these two chips. The scaling correction accounts for errors such as a
pipeting error where,

Iij

=

Iik αjk

if, α = 2, then the chip, j, may have received 2X more RNA sample than chip, k. This
equation is equivalent to,

Eij = Log2αjk + Eik
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where, the log of the product is equal to the sum of the logs. Finally, the expression
statistic (E) is equal to the log base 2 of intensity (I). Analyzing microarray data in terms
of E rather than I is the preferred convention since I values would not include zero,
hence, making the plots conceptually harder to comprehend.
E = Log2 I ∴ 2 E = I

2.2 Results
2.2.1 Each mutant displays a unique whole genome expression profile and the
differential expression plots (DE plots) illuminate three distinct properties of the
mutants compared to wild type.

Mutants were analyzed for whole genome expression differences as compared to
wild type parasites in order to identify gene(s) that contribute to the mutant phenotype.
Each parasite line was cultured under tachyzoite growth conditions (high CO2), 0h, or
CO2 starvation conditions for 72 hours (bradyzoite induction conditions) and then
subjected to microarray hybridization and analysis. The DE plots allow us to visualize
which gene(s) behave like wild type and which gene(s) differ in expression levels
compared to wild type. DE plots for each mutant versus wild type show a unique whole
genome expression profile and allow us to visualize three distinct properties of the
mutants: (1) genes that respond similarly to wild type under inductions, (2) genes that do
not respond similarly to wild type under induction conditions (72h), and (3) the degree of
leakiness. Genes that behave similarly to wild type (feature 1) plot along the diagonal
line (black) and genes that do not respond (feature 2) to bradyzoite induction conditions
plot along the horizontal line (black) (Figure 12).
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Figure 12. Differential gene expressionplots for wildtype versus each mutant.

For clarity, the DE plots of two mutants (B7 and 13P) will be used to discuss the
features illuminated by these plots (Figure 13).

Figure 13. DE plots for wildtype versus mutant B7 (left) and wild type versus
mutant 13P (right).
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The details of these DE plots are discussed in the text.

Gene expression levels of wild type bradyzoites (B) minus gene expression levels of wild
type tachyzoites (T) are plotted along the x-axis. For wild type parasites, the genes that
are up-regulated ≥ 2 fold after 72h bradyzoite induction compared to extracellular
tachyzoites (0h) have an expression value ≥ 1 (B-T ≥ 1), which corresponds to a fold
change value ≥ 2 (B/T ≥ 2). These genes are encircled with a black oval on the x-axis
and represent bradyzoite up-regulated genes. The expression levels of mutant
bradyzoites (B) minus mutant tachyzoites (T) are plotted on the y-axis for each mutant.
Again, for mutant parasites, the genes that are up-regulated ≥ 2 fold after 72h bradyzoite
induction compared to extracellular tachyzoites (0h) have an expression value ≥ 1 (B-T ≥
1), which corresponds to a fold change value ≥ 2 (B/T ≥ 2). It is important to note that
the extent to which bradyzoite up-regulated genes are expressed is quite different
between wild type (~2 - 256 fold change) and mutants (~2 - 8 fold change). As
illustrated in Figure 13, genes that are encircled by the green oval represent the genes that
respond to bradyzoite induction conditions (72h) at a much lesser extent compared to
wild type parasites. These genes represent the leakiness of the mutants (feature 3) (a
fraction of the mutant parasite populations do form bradyzoites) and the
immunofluorescence assays of bradyzoite-specific markers (Figure 5) show this as well.
When we look at the DE plots of all mutants (Figure 12), we observe that
mutants, B7, 11K, 11P, 7K and P11, show little or no response to low CO2 (72h) (genes
that cluster along the black horizontal line), while mutants, 12K and 13P, show a split
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(sideways “Y” shaped line) in their gene expression pattern, where a subset of genes
respond similarly to wild type and a subset of genes do not respond to CO2 starvation
(72h).
2.2.2 The wild type time course for bradyzoite induction suggests a great difference
in gene expression between extracellular parasites and intracellular low CO2
parasites.

We performed a bradyzoite induction time course with wild type parasites and
analyzed the whole genome expression profiles at the following time points: 0h
(extracellular tachzyoites), and 24h, 36h, 48h, and 72h post-bradyzoite induction. Genes
that were upregulated ≥ 2 fold at 72h compared to 0h (n = 788) clustered into three
distinct subsets; early genes (n = 356), middle genes (n = 183), and late genes (n = 249)
(Figure 14A).

36

Figure 14. Bradyzoite up-regulated genes cluster into three distinct patterns.

The first subset of genes (early gene cluster) is expressed at 24h post bradyzoite induction
(n = 356) and significantly induce from 0h to 24h, remain highly expressed 24h-48h, and
then begin to decrease at 72h post bradyzoite induction. The second subset of genes
(middle gene cluster) is moderately induced from 0h to 24h, remain steady 24h-48h, and
then increase expression at 72h post-induction (n=183). The third subset of genes (late
cluster) are induced between 48h and 72h post bradyzoite induction ( n = 249 ) and are
repressed from 0h to 48h.
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2.2.3 Bradyzoite differentiation mutants are ‘stuck’ in the intracellular low CO2
state (WT24) even though they are extracellular.

When we look at the expression profiles of the mutants in the context of the wild
type bradyzoite induction time course we see that 5/7 of the mutants are ‘stuck’ in the
intracellular low CO2 parasite state (Figure 14B). State modeling is a statistical method
that involves segregating all samples into the state with which they most closely belong
to based on the frequency of the gene expression patterns observed for each sample at
each time point. This method quantitatively describes the phenomenon that we see by
eye; mutants are ‘stuck’ in an intracellular low CO2 parasite state (state modeling data not
shown, J. Bond). Wild type parasites induce the intracellular low CO2 subset of genes at
24h post bradyzoite induction (early genes) as compared to 0h (extracellular tachzyoites)
but some of the mutants already have these genes on at time 0h and 72h. These early
genes appear to represent the gene expression profile of an intracellular tachyzoite (see
Figure 10 for clarity). Interestingly, this phenomenon is only seen in 5/7 mutants (B7,
11K, 11P, 7K and P11), while the other 2 mutants (12K and 13P) behave like wild type
for this subset of genes. Wild type parasites moderately induce a subset of genes between
24h-48h (middle genes) and then the expression significantly increases by 72h. The
middle genes appear to represent those genes involved in the transition from tachyzoites
to bradyzoites and respond to low CO2 (please refer to Figure 10 for clarity). Lastly, wild
type parasites significantly induce a subset of genes between 48h-72h (late genes) and
this subset of genes is not induced in any of the mutants.
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2.2.4 Wild type and mutant extracellular tachyzoites show significantly different
expression profiles, but mutant extracellular tachyzoites look similar to wild type
intracellular low CO2 parasites.

A contingency table comparing whether each replicate, for each sample, behaves
more like extracellular tachyzoites or intracellular low CO2 parasites illustrates two
distinct results: (1) extracellular wild type parasites have a different expression profile
from extracellular mutant parasites (p < 0.001) and (2) extracellular mutant parasites have
an expression profile that is significantly similar to wild type low CO2 parasites (24h) (p
< 0.03) (Figure 15).

Figure 15. A contingency table showing that extracellular wild type and mutants are
different but extracellular mutants are similar to wild type intracellular low CO2
parasites.
The parasite lines are listed in the first column. The second column shows how many replicates,
for each sample, behave more like extracellular tachyzoites (left of slash) or intracellular low CO2
parasites (right of slash), at time 0h. The third column shows how many replicates, for each
sample, behave more like extracellular tachyzoites (left of slash) or intracellular low CO2
parasites (right of slash), at time 72h.

We can also connect the corresponding biology of each state based on the genes that are
represented in each state. For example, genes involved in DNA replication and the cell
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cycle are present in both extracellular tachyzoites and intracellular low CO2 parasites
(early genes), but are not represented by the middle genes of intracellular low CO2
parasites (genes that appear to represent early bradyzoites) (Figure 16).

Figure 16. DNA replication and cell cycle genes segregate into the different states
based on the relevant biology of each state.

Extracellular tachyzoites and bradyzoites arrest their cell division while intracellular
tachyzoites are actively replicating. It is important to note that although DNA
replication/cell cycle genes are represented in the extracellular tachyzoite state, they do
not appear to represent an actively replicating parasite. The extracellular tachyzoites
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express genes involved in DNA repair and the regulation of progression through the cell
cycle. For example, cullin belongs to a family of proteins that are involved in negative
regulation of the cell cycle. While the ‘early’ genes represented by the intracellular low
CO2 parasites show clear trademarks of active DNA replication, the ‘middle’ genes
represented by the intracellular low CO2 parasites exhibit no DNA replication/cell cycle
genes. Again, the mutants are ‘stuck’ in an intracellular low CO2 parasite state and thus
are expressing a gene profile representative of actively replicating parasites even though
the mutants are extracellular.
2.2.5 R Score Analysis and the identification of genes that show the most variation
in expression levels across all samples.

The R score is a statistic that helps us to identify those genes that express most
differently across all samples and all time points. We are interested in identifying these
genes because they are likely to represent those genes involved in the mechanism of the
transition and will serve as candidate target genes for further study. The rationale behind
this idea includes several key points: (1) we know that the mutants have been generated
by insertional mutagenesis which disrupted a single locus in each mutant leading to
defects in bradyzoite formation, (2) we know that each mutant has been disrupted at
distinct positions in the genome and (3) each mutant displays a unique whole genome
expression profile (albeit, with some common themes). Genes that behave similar
among samples most likely represent the genes that are either upstream or downstream
from the block in bradyzoite formation. For example, a subset of genes that are similar
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among all mutants may be genes that do not allow appropriate arrest in the cell cycle and
thus will remain upregulated in the mutants (these genes may represent genes upstream in
the bradyzoite differentiation cascade). Genes that express similarly in all samples,
including wild type, may represent end state bradyzoites (reflecting the leakiness of the
mutants). Again, these genes are uninteresting and reflect genes that are downstream
from the block in bradyzoite formation. Most interesting, are those genes that vary most
among samples and are the genes that lie within the range of the cascade in which
transition can be blocked. Given that we have several distinct mutants to compare, it
would be interesting to see which of the most varied genes (highest R scores) are similar
or different among different mutants. Not only could these genes serve as candidate
genes for further study of the differentiation pathway but we could also use these genes to
dissect the order of which mutants were disrupted in which place along the transition.
Unfortunately, the details of these analyses will not be discussed here because complete
analysis of these hypotheses go beyond the scope of the current study.
The top 3 genes that have the highest R scores are: R=7807 (551.m00236hypothetical), R= 1109 (44.m02759- supt5h), and R= 520 (113.m00800- DNA primase)
(Figure 17).
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Figure 17. The residual values for genes with the highest R scores.
Residual values represent how different the observed expression of a given gene differs from the
expected expression (based on wild type state modeling). A residual value close to 0 means that
the expected value is similar to the observed value. Gene 551.m00236 is highly expressed in
mutant 7k compared to all other samples (yellow). Gene 44.m02759 is also highly expressed in
mutant 7K compared to all other samples (red). And, gene 113.m00800 is highly expressed in all
samples except for mutant B7, mutant P11 and wild type.
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Supt5h is a subunit of a complex involved in repressing transcription elongation (Bethyl
Laboratories, Inc.). DNA primase is one of the large subunits that comprises the alpha
DNA polymerase:DNA primase complex. This complex catalyzes the synthesis of an
RNA primer on the lagging strand of replicating DNA (ToxoDB).
2.3 Methods

RNA Isolation.
Total RNA was extracted from parasites that had freshly lysed the host cells, extracellular
tachyzoites, or 72h post induction bradyzoites. Infected monolayers were scraped,
dounce homogenized and filtered through a 3micron filter (Millipore). Parasites were
centrifuged and washed 2 times with 1X phosphate buffered saline (PBS) in DEPC water.
Pellets were resuspened in lysis buffer RLT (Qiagen) and passed through a 26G needle.
Finally, samples were processed through the RNA mini kit (Qiagen) and DNase treated
on the column. (Elution with 50°C RNase-free water increased our yield). RNA
concentrations were measured on the NanoDrop ND 1000 UV Vis spectrophometer.

2.4 Discussion

Our data strongly suggest that the expression profile of wild type extracellular
tachyzoites (t=0h) is significantly different from the expression profile of intracellular
low CO2 parasites (t=24h), which demystifies the assumption in the Toxoplasma research
community that parasites grown under tachyzoite growth conditions are all the same
whether or not they are actively replicating intracellular tachyzoites or ‘freshly’ egressed
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extracellular tachyzoites. This result has important implications for future experimental
design in our own laboratory as well as other interested laboratories in the Toxoplasma
research community. It is now clear that the tachyzoite state can be broken up into two
distinct states, the extracellular tachyzoite state in which parasites are outside of the host
cell, presumably poised to survive by invading a new host cell or to die, since they are
obligate intracellular parasites. Once the parasites have invaded the host cell they
transition to the intracellular tachyzoite state where they rapidly replicate and then lyse
the host cell, at which point they transition back to the extracellular state (if left for some
yet to be determined time period without an opportunity to invade another host cell).
Some extracellular mutants (B7, 11K, 11P, 7K and P11) show a different
expression profile compared to wild type extracellular parasites under both high CO2
(t=0h) and low CO2 (t=72h), but interestingly, these mutant extracellular parasites have
expression profiles that are strikingly similar to wild type intracellular low CO2 parasites.
In contrast, the other two mutant parasite lines (12K and 13P) show a similar expression
profile as wild type extracellular parasites under high CO2, but look like wild type
intracellular low CO2 parasites after 72h of induction. This result suggests that there is a
commonality of regulation in switching from state to state. Mutants B7, 11K, 11P, 7K
and P11 are not only defective in switching to the bradyzoite state (72h) (they get ‘stuck’
in the intracellular low CO2 parasite state) but they can’t switch to the extracellular
tachyzoite state either (0h). Interestingly, mutants, 12K and 13P, also get ‘stuck’ in the
intracellular low CO2 parasite state after 72h of induction and cannot form bradyzoites,
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but these mutants are able to switch to the extracellular tachyzoite state under high CO2
(0h).
We propose a working model to explain where the mutants are blocked along the
bradyzoite differentiation pathway (Figure 18).

Figure 18. A working model.

Figure 18A describes an oversimplified pathway for the tachyzoite to bradyzoite
transition. Tachyzoites sense a stress signal and then the transition to bradyzoites is
initiated, where the cell cycle slows down and bradyzoite-specific genes are induced.
Figure 18B illustrates the tachyzoite to bradyzoite transition in the context of what we
learned from our microarray analysis. Gene expression levels for early, middle and late
genes are shown for each state along the transition for which we have data. Extracellular
parasites induce early genes, perhaps after sensing an environment containing host cells.
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Extracellular parasites invade host cells and radiply replicate until they lyse the host cell
during egress and will either invade new host cells or initiate transition upon sensing a
stress signal. Upon initiation of the transition, early gene expression levels reduce and
cell cycle arrest occur. (Genes that represent actively replicating parasites are
represented in the early gene cluster). Middle genes are induced and then late genes are
induced and this gene induction results in the formation of bradyzoites. We hypothesize
that two events, cell cycle arrest and sensing an extracellular signal, are required to enter
into the extracellular tachyzoite state represented by repression of early, middle and late
genes. Additionally, cell cycle arrest and sensing a stress signal are the two events
required for entering into the brdayzoite state. Mutants B7, 11K, 11P, 7K and P11 are
‘stuck’ in the intracellular state, represented by early gene induction, at time = 0h and 72h
post induction. This result suggests that these 5/7 mutants are in some way defective in
cell cycle arrest and cannot enter into the extracellular state, represented by repression of
early middle genes, nor can they enter into the bradyzoite state. Mutants 12K and 13P
can enter into the extracellular state, represented by repression of early, middle and late
genes, at time = 0h, but are ‘stuck’ in the intracellular state, represented by early gene
induction, after 72h post induction. This result suggests that these two mutants are, in
some way, defective in sensing the stress signal and cannot enter into the bradyzoite state.
However, these two mutants can enter into the extracellular tachyzoite state, represented
by repression of early, middle and late genes, so they are not defective in cell cycle arrest
and sensing the extracellular signal.
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Radke, et al., 2005, performed analysis on SAGE libraries that were created for
nine different time points during development of Toxoplasma gondii in order to better
understand the molecular basis of the developmental switch during bradyzoite
differentiation [40]. 5/9 of the libraries analyzed consisted of a developmental time
course of in vitro sporozoite to bradyzoite differentiation. These five libraries included;
oocysts containing mature sporozoites, emerging parasites 4 days post inoculation with
the mature sporozoites, rapidly growing parasites 6 days after inoculation with infectious
sporozoites, intracellular parasites 7 days after inoculation with infectious sporozoites
(and 24h post bradyzoite induction- alkaline conditions), and slowly growing parasites 15
days after inoculation of infectious sporozoites (and 266h post bradyzoite induction).
Radke et al., 2005, also analyzed 4 other SAGE libraries that included 3 intracellular
tachyzoite timepoints (TypeI-RH, TypeII-Me49B7 and TypeIII-Vegmsj) and a 72h post
bradyzoite induction time point for a TypeII strain (Vegmsj) [40].
We can make comparisons between the Radke et al., 2005 study and our
microarray analysis. Again, the time points in our wild type parasite time course
included; extracellular tachyzoites (0h), and 24h, 36h, 48h and 72h post bradyzoite
induction (CO2 starvation) for the TypeI RH strain. We report that our 24h post
induction time point includes a mixture of rapidly growing intracellular tachyzoites and
transitioning parasites (due to our experimental design in which we used extracellular
tachyzoites as our time 0h we are able to see the gene expression patterns for both rapidly
growing tachyzoites (represented by early genes) and transitioning parasites (represented
by middle genes) in our 24h sample). Despite the strain and bradyzoite induction
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condition differences between our study and the Radke et al., 2005 study, we can draw
parallels in the observations of both studies. Radke et al., 2005, show that day 6
(intracellular parasites 6 days after sporozoite inoculation and 48h post invasion of
‘emerging’ parasites) parasites induce expression of genes that indicate active nuclear
replication and cell division compared to day 7 (intracellular parasites 7 days after
sporozoite inoculation, 72 after invasion with ‘emerging’ parasites and 24h post
bradyzoite induction) parasites [40]. This observation is consistent with our observation
of our 24h post induction sample, where the early genes in this sample represent actively
replicating parasites but the middle genes in this sample show reduced expression of
genes indicative of a rapidly growing parasite. Thus, both studies show that gene
expression in parasites that have been exposed to bradyzoite induction conditions for 24h
show reduced replication. These observations are not surprising since it has been well
established that one of the key features that distinguish tachyzoites from bradyzoites is
growth rate. Therefore, we expected to see replication-related genes induced in
intracellular tachyzoites compared to parasites that have been exposed to bradyzoite
induction conditions.
In addition to the intracellular parasites (with and without exposure to induction
conditions) showing differential expression of replication-related genes, we also observed
an interesting expression pattern in extracellular parasites. In our microarray study we
observed that extracellular tachyzoites show reduced expression of replication-related
genes compared to 24h post induction (representing rapidly growing tachyzoites-early
genes and transitioning parasites-middle genes). Radke, et al., 2005 analyze a sample of
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parasites that are ‘emerging’ 4 days after inoculation with sporozoites and they observe
that this sample (day 4) has reduced expression of cell growth-related genes. It is
important to note that the Radke et al., 2005 ‘emerging’ parasites are of sporozoite origin,
where as, our ‘freshly’ egressed parasites are tachyzoites.
Interestingly, we observe the induction of known bradyzoite markers (ie., BAG1)
after 24h of bradyzoite induction, whereas Radke et al, 2005, do not observe induction of
‘mature’ bradyzoite markers (ie., BAG1) in their day 7 sample (intracellular parasites 7
days after sporozoite inoculation, 72h post invasion of ‘emerging’ parasites and 24h post
bradyzoite induction). However, Radke et al., 2005, do observe BAG 1 induction in their
72h post bradzyoite induction sample (Vegmsj). Their studies also show that 72h post
induction reveals a more mature bradzyoite compared to 15 days post sporozoite
inoculation. This result suggests that in vitro differentiation from sporozoite to
bradzyoite is less efficicient compared to in vitro differentiation between intracellular
tachyzoite to 72h post bradyzoite induction differentiation [40]. The difference in strain
and induction conditions could account for the discrepancies between our study and the
Radke et al., 2005, study in regards to BAG1 expression.
In conclusion, the results from our microarray studies have the following
implications: (1) the mutants break into two distinct families where mutants 12K and 13P
have been disrupted in such a way that they can still sense their environment (high CO2)
and alter their gene expression accordingly, whereas mutants B7, 11K, 11P, 7K and P11,
cannot sense their environment and therefore do not alter their gene expression
(perpetually ‘stuck’ in an intracellular low CO2 state), or (2) there is a technical issue
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with the experimental design in which extracellular parasites were harvested during a
range of time resulting in some parasites (B7, 11K, 11P, 7K and P11) not being outside
of the host cell long enough to show alterations in their gene expression (we have
designed additional experiments to rule out this latter possibility and the details of those
experiments are discussed in the last chapter).
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CHAPTER 3: CHARACTERIZATION OF BRADYZOITE
DIFFERENTIATION MUTANT B7 IN TOXOPLASMA GONDII

Abstract

Bradyzoite differentiation mutant B7 was generated by Matrajt et al., 2002, as described
in Chapter 1. I have focused this branch of my research on the characterization of the
disrupted locus in this mutant. The insertional mutagenesis vector (described in section
1.5) disrupted a putative non-coding RNA that was isolated from a bradyzoite cDNA
library, contains no substantial open reading frame, and is developmentally regulated.
B41 becomes induced under bradyzoite induction conditions in wild type but expression
is reduced in the mutant. B41 is alternatively spliced into a short (1.0kb) and long
(2.2kb) transcript. An EST (13803210) that is located just downsteam from the insertion
site was isolated from a tachyzoite cDNA library and its expression remains induced in
the mutant under bradyzoite conditions. We performed overexpression experiments with
EST 13803210 and determined that this EST is not a key player in bradyzoite formation.
Because non-coding RNAs are known to play a role in transcriptional regulation in other
species we used a luciferase reporter assay to test if B41 regulates the expression of EST
13803210 and it does not. Finally, we were able to complement the mutant phenotype
using a cosmid complementation plasmid.
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3.1 Introduction

Plasmid rescue and inverse PCR were previously performed on mutant B7
genomic DNA in order to identify the locus that had been disrupted during insertional
mutagenesis (unpublished data, M. Matrajt). The insertional mutagenesis vector
integrated into the 3’ end of a putative non-coding RNA gene (B41) that was isolated
from a bradyzoite cDNA library and contains no substantial open reading frame (ORF).
Immediately downstream from the mutagenesis vector there is an EST (13803210) that
was isolated from a tachyzoite cDNA library and has no homology to any known genes
(Figure 19A, unpublished data, M. Matrajt).

Figure 19. Genomic location of the insertional mutagenesis vector in mutant B7 and
RT-PCR expression results for the genes on either side of the insertion.
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A. The insertion integrated into the 3’ end of B41 and just upstream from EST 13803210. B. RTPCR for wild type (WT) and mutant B7 (M) under tachyzoite (T) and bradyzoite (B) induction
conditions (72h post induction) was performed for the following genes; alpha-tubulin (strong
constitutive gene used as a loading control), enolase I (known bradyzoite-specific gene used as a
positive control of bradyzoite induction), B41 and EST 13803210.

A non-quantitative reverse transcriptase polymerase chain reaction (RT-PCR) was
performed in order to investigate the expression levels of B41 and EST 13803210
(unpublished data, M. Matrajt) (Figure 19B). Samples were measured from both wild
type and mutant parasites under tachyzoite (‘freshly’ egressed extracellular tachyzoites)
and bradyzoite (72h post bradyzoite induction) conditions. The strong constitutively
expressed gene, alpha-tubulin, was run as a positive control to normalize loading of each
sample and its expression profile is shown in the first panel of Figure 19B. Enolase I, a
known bradyzoite-specific gene, shown in the second panel, was run as a positive control
of bradyzoite induction. Note that enolase I expression is only detected in samples that
were subjected to bradyzoite induction conditions (72h) and is not present in samples
grown under tachyzoite conditions. The expression profile of B41 is shown in the third
panel and expression is only detected in wild type parasites grown under bradyzoite
induction conditions, confirming that it is a bradyzoite-specific gene. However,
expression of B41 is lost in the mutant under bradyzoite induction conditions, which is
consistent with the result that this gene is physically disrupted in the mutant. The fourth
panel of Figure 19B shows the expression profile of EST 13803210 but, because the
method used in this experiment was a non-quantitative RT-PCR, it is ambiguous whether
the small differences seen in this panel are significant. When I began my research in the
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Matrajt laboratory, I continued with the characterization of the disrupted locus in the
bradyzoite differentiation mutant, B7.
3.2 Results

3.2.1. B41, a bradyzoite-specific gene, shows reduced expression in the mutant and
EST 13803210, a tachyzoite-specific gene, does not get down-regulated under
bradyzoite conditions in the mutant.

A quantitative RT-PCR was performed on B41 and EST 13803210 in order to
confirm the previous non-quantitative RT-PCR results and to obtain a quantitative
measure of the expression profiles of EST 13803210 (Figure 20).

Figure 20. Quantitative RT-PCR of B41 and EST13803210 in wild type and mutant
parasites under both tachyzoite and bradyzoite conditions.
The disrupted locus is shown for context and the details of this experiment are discussed in the
text.
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RNA was isolated from both wild type and mutant parasites under tachzyoite and
bradyzoite conditions. Analysis of B41 included a time course where we analyzed the
expression profile of B41 under tachyzoite (T) (‘freshly’ egressed extracellular
tachyzoites) and bradyzoite conditions (B-day 2 and B-day 4, post induction). Analysis
of EST 13803210 was performed in the same manner as the previous study where we
analyzed the expression profile under both tachyzoite (T) and bradyzoite conditions (B)
(72h post-induction). The strong constitutive gene, alpha-tubulin, was used to normalize
each sample. The expression profiles of B41 are shown in the left panel and each sample
is expressed as a value relative 1.0, where wild type under tachyzoite conditions was
chosen to equal 1.0. The expression of B41 in wild type parasites is significantly induced
over time under bradyzoite induction conditions; 5.3-fold induction at day 2 and then
24.6-fold induction at day 4 compared to expression under tachyzoite conditions.
However, mutant B7 shows significantly reduced expression over time; 2.8-fold
induction at day 2 and then 7.8-fold induction at day 4. The expression profile of EST
13803210 shown in the right panel of Figure 20 confirms that this gene is a tachyzoitespecific gene with expression levels reduced 3-fold under bradyzoite conditions (72h
post-induction) compared to tachyzoite conditions. However, expression of EST
13803210 is not down-regulated under bradyzoite conditions in the mutant. In
conclusion, B41 is a developmentally regulated gene whose expression is reduced in the
mutant under bradyzoite induction conditions. EST 13803210 is a tachyzoite-specific
gene that gets down-regulated in wild type parasites under bradyzoite induction
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conditions but its expression remains on under both tachyzoite and bradyzoite conditions
in the mutant.
3.2.2 B41 is a large non-coding RNA (contains no ORF) that is alternatively
polyadenylated.

RACE, Rapid Amplification of cDNA Ends, is a method used to identify the full length
of a transcript. We used 5’ and 3’ RACE to identify the entire length of the B41 gene and
determined that B41 is alternatively polyadenylated resulting in two large (1.0kb and
2.2kb) transcripts (Figure 21).

Figure 21. A schematic of the alternatively spliced products of the B41 gene.
The details of this schematic are discussed in the text.

We aligned the B41 sequences (1.0 kb and 2.2kb) to the Toxoplasma genome and the
position of this gene is on chromosome VI: 66555..67494(1.0kb)/69155(2.2kb) and the
insertion is located on chromosome VI at position 69000. We also aligned the sequence
of EST 13803210 to the Toxoplasma genome and this EST is located on chromosome
VI:69353..71610.
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3.2.3. The putative non-coding RNA, B41, does not regulate the expression of the
EST 13803210.

We hypothesized that B41 is functioning as a non-coding RNA (ncRNA)
involved in the regulation of gene expression during bradyzoite differentiation. We know
that in wild type parasites B41 gets upregulated and EST 13803210 gets down-regulated
under bradyzoite induction conditions. It is well documented in the literature that large
ncRNAs that are developmentally regulated and polyadenylated play an important role in
regulating the expression of other genes that are adjacent to the site of transcription of the
large nc-RNA [39]. The ncRNAs regulate their neighboring genes by recruiting
chromatin remodelers which results in silencing the adjacent genes at a single site,
throughout the genomic region, or across the entire chromosome [39]. Since B41 is
upregulated and EST 13803210 is downregulated in wild type parasites under bradyzoite
conditions, we hypothesize that B41 is silencing the expression of EST 13803210 under
bradyzoite conditions. Because expression of B41 is lost in the mutant, it is unable to
repress the expression of EST 13803210 and this may cause the mutant phenotype.
In order to test if B41 is silencing EST 13803210, two constructs were made: (1)
the luciferase gene driven by the EST 13803210 promoter (pEST-LUC) and (2) the
luciferase gene driven by the EST 13803210 promoter plus the entire B41 gene
(including 1000bp upstream from the B41 transcription start site in attempt to include the
entire B41 promoter) (B41-pEST-LUC). If B41 does function in silencing the EST via
its promoter then we would expect that transgenic parasites containing pEST-LUC will
be able to express luciferase under both tachyzoite and bradyzoite conditions because
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B41 is not present to silence luciferase. But, transgenic parasites expressing B41-pESTLUC will only express luciferase under tachyzoite conditions because B41 is able to
silence luciferase expression (Figure 22A).

Figure 22. Luciferase reporter assays show that B41 does not regulate EST
13803210.
A. The idea behind this experimental design is that under bradyzoite conditions B41 gets
upregulated and EST 13803210 gets down-regulated. We wanted to test the hypothesis that B41
regulates the expression of EST13803210. The two constructs used in this experiment are
illustrated and the expected results are shown. B. Luciferase activity is represented as the fold
difference of activity of parasites expressing B41-EST0LUC over the activity of parasites
expressing EST-LUC.
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Wild type parasites were transiently transfected with B41-EST-LUC or EST-LUC and
subjected to bradyzoite induction conditions for 0h, 48h, 96h and 120h, and luciferase
activity was measured in a luminometer. Luciferase activity is represented as the fold
difference of luciferase activity of the B41-EST-Luc parasites over the activity detected
in the EST-LUC parasites. A ratio of 1.0 would mean that both parasite lines were
expressing the same amount of luciferase and thus, luciferase activity would be the same
for each parasite line. Both parasite lines expressed the same amount of luciferase under
both tachyzoite (0H) and bradyzoite conditions (48H, 96H and 120H, post induction)
(Figure 21B). This observation suggests that B41 is not silencing the EST. However,
until we take a closer look at the expression profiles of the other genes at this locus, we
cannot rule out the possibility that B41 is affecting the expression of other genes in this
locus (that may, in turn, influence the expression of EST13803210).
3.2.4 B41 is the only gene within 100kb of the insertion that has its expression
affected in mutant B7.

The gene expression levels of 16 genes within 100kb of the insertion site were
analyzed using the whole genome microarray data in order to determine if the expression
level of any of the other genes adjacent to the insertion were affected in mutant B7
(Figure 23).
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Figure 23. Expression has not been affected in any other gene within 100kb of the
insertion.

Gene expression for wild type and mutant are represented by fold change of
expression under bradyzoite conditions over expression under tachyzoite conditions for
each gene. A ratio value of 1.0 would mean that expression is unchanged between
tachyzoites and bradyzoites. There is no change in expression level between tachyzoites
and bradyzoites in wild type or mutant B7. B41 is the only gene within 100kb of the
insertion that has been affected in the mutant (aside from EST 13803210 which we will
address in the following section).
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3.2.5. Overexpression analysis of EST 13803210 confirms that this gene does not
play a key role in bradyzoite differentiation.

Wild type parasites express EST 13803210 under tachyzoite conditions and
downregulate its expression under bradyzoite conditions. However, the mutant parasites
are unable to downregulate the expression of EST 13803210 under bradyzoite conditions.
It is possible that EST 13803210 must get down-regulated in order for the parasites to
switch to the bradyzoite form. Since EST 13803210 is not getting downregulated in
mutant B7 under bradyzoite induction conditions, it is possible that this gene is causing
the mutant phenotype. In order to test this hypothesis, we overexpressed EST 13803210
in wild type parasites and subjected these parasites to bradyzoite induction conditions
with the expected result that these parasites would not be able to form bradyzoites if the
hypothesis is correct (Figure 24A). The rationale for this experimental design was that
overexpressing EST 13803210 would mimic at least one aspect of the mutant phenotype
in that this gene is not downregulated under bradyzoite conditions.
Wild type parasites were transfected with a construct containing EST 13803210
under the control of the strong constitutive alpha-tubulin promoter and these parasites
were selected with chloramphenicol to generate a stable transgenic line. The transgenic
parasites were subjected to bradyzoite conditions and assayed for bradyzoite specific
markers using immunofluorescence assay for a known bradyzoite surface antigen (4F8)
and Dolichos lectin staining. The transgenic parasites expressed the same amount of
bradyzoite specific markers under bradyzoite conditions as the wildtype parasites
expressed (Figure 24B). We also performed a quantitative RT-PCR (qRT-PCR) on wild
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type and transgenic parasites to confirm that EST 13803210 was indeed overexpressed in
the transgenic parasite line. The qRT-PCR showed that the transgenic line expressed
EST 13803210 80-fold higher than wild type parasites (Figure 24C).

Figure 24. Overexpression experiments show that EST 13803210 is not a key player
in bradyzoite formation.
A. Expected results are shown for wild type (WT), mutant B7, and transgenic parasites
(overexpressing EST 13803210). B. Immunofluoresence assay for bradyzoite-specific markers,
surface antigen (4F8) and Dolichos lectin. The top panel shows one bradyzoite cyst stained with
both markers under phase and fluorescence microscopy. The bottom panel shows the percentage
of vacuoles that did not stain for the bradyzoite-specific markers (bradyzoite induction of wild
type parasites is never 100%) for both wild type (WT 7-1) and transgenic parasites (7-1EST). C.
qRT-PCR for expression of EST 13803210 in wild type (WT(7-1B-3) and transgenic (7-1B-3EST) parasites after 3days of induction confirm that the transgenic line overexpresses EST
13803210.
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These results suggest that EST 13803210 is not a key player in bradyzoite formation. It
could be involved but is not sufficient to induce bradyzoite differentiation.
3.2.6 Cosmid complementation in mutant B7 restores the mutant phenotype to
wild type-like levels.

Mutant B7 was complemented using the 40kb cosmid, PSBLS72 (generous gift
from M. Gubbels). This cosmid contained six genes including B41 (Figure 25).

Figure 25. A schematic of the cosmid used to complement the mutant B7 phenotype
and the genes that are located on this cosmid.

Mutant parasites were transfected with the cosmid and stable lines were selected with the
drug, phleomycin. Transgenic parasites were then subjected to bradyzoite induction
conditions for 72h and expression of bradyzoite-specific surface antigen (4F8) was
measured as the number of positive vacuoles per 100 vacuoles counted. The
complemented parasite line (B7 complement) was compared to wild type (parental 7-1)
and mutant B7 (Figure 26).
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Figure 26. Immunofluorescence assay of the expression of a bradyzoite surface
antigen in wild type, mutant B7 and B7 complement shows increased expression in
the B7 complement compared to mutant B7.

Replication rate was also measured in the B7 complemented strain and compared to wild
type and mutant B7 (Figure 27).

Figure 27. Replication rate assay shows that B7 complement has reduced replication
rate compared to mutant B7.
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After 3 days of bradyzoite induction the average number of parasites per vacuole were
counted in the B7 complement and compared to wild type and mutant B7. Interestingly,
the complemented strain shows reduced replication rate but not reduced to the level of
wild type.
In conclusion, cosmid complementation restored the mutant phenotype to wild
type-like levels. It is important to note that B41 is the only gene on cosmid PSBLS72
that has its expression affected in the mutant and this result adds to the evidence
supporting our hypothesis that B41 is responsible for the mutant phenotype.
Interestingly, the 40kb cosmid was sufficient for complementation mutant B7 but the
plasmid containing only the B41 gene was not able to complement the mutant. The
original plasmid used for complementing mutant B7 contained the entire B41 gene
(2.2kb) plus 1000bp upstream from this gene in order to capture the endogenous
promoter of B41. The cosmid contains the entire B41 gene including ~7500bp of
genomic sequence down stream from the 3’end of the B41 gene and ~31,000bp upstream
from the transcription start site of B41. Our results suggest that there are functionally
important sequences within the cosmid that were not included in the orginal plasmid that
allowed for complementation of mutant B7.
3.3 Methods
Parasite growth and differentiation.

The parental line, RH ΔHXGPRT ΔUPRT (deleted at both HXGPRT and UPRT
loci; Bohne and Roos, 1997), and mutant B7 tachyzoites were maintained by serial
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passage in primary cultures of human foreskin fibroblast (HFF) cells, as described
previously (Roos et al., 1994). ΔUPRT tachyzoite parasites can be induced to form
bradyzoites in vitro when subjected to low CO2 conditions (0.03%) resulting in
pyrimidine starvation (Roos et al., 1994; Boothroyd et al., 1995). Bradyzoite induction
was accomplished by inoculating tachyzoites into an HFF host cell monolayer in minimal
essential media without NaHCO3 that contains Earles salts 25mM HEPES (Gibco). The
cultures were then equilibrated at pH7 and incubated at 37°C. All measurements were
taken on extracellular tachzoites or 72h post induction bradyzoites.
RNA Isolation.

Total RNA was extracted from freshly egressed, extracellular, tachyzoites or 72h post
induction bradyzoites. Infected monolayers were scraped, dounce homogenized and
filtered through a 3micron filter (Millipore). Parasites were centrifuged and washed 2
times with 1X phosphate buffered saline (PBS) in DEPC water. Pellets were resuspened
in lysis buffer RLT (Qiagen) and passed through a 26G needle. Finally, samples were
processed through the RNA mini kit (Qiagen) and DNase treated on the column. (Elution
with 50°C RNase-free water increased our yield). RNA concentrations were measured
on the NanoDrop ND 1000 UV Vis spectrophometer.
Luciferase Assays

Wild type parasites were transiently transfected with pLUC, EST-LUC or B41-ESTLUC. Primers used to generate the LUC constructs are as follows: 969-ApaI: 5’
ATCGTCGGGCCCAGGCGTCTGCGTCGATGG 3’, 3775-ApaI: 5’
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ATCGTCGGGCCCACTGGGGGAGGAAGCTCCTAC 3’, 4640-BglII: 5’
GTTGGAAGATCTTGTGATGAGAGACGTTTTCTCG 3’. pLUC was digested with
ApaI/BglII and ligated with EST promoter (PCR product 3775-ApaI/4640-BglII) or B41EST promoter (969-ApaI/4640-BglII). Parasites were tranfected with the constructs and
selected with chloramphenicol to select for stable transgenic lines. Bradyzoite induction
conditions used in this experiment were CO2 starvation conditions. Luciferin subtrate
was reconstituted with buffer, media was apirated from cells/parasites, washed with 1X
PBS, 900ul 1X CCLR was added to cover cells, cells were scraped and added to a tube
on ice and luciferase activity was measured on a luminometer.
Immunofluorescence Assays

HFF cells were grown on coverslips within a 6-well plate and inoculated with
extracellular tachyzoites. Parasites were grown under tachyzoite or bradyzoite conditions
for 72 hours. In brief, the cells were washed with 1X PBS and fixed in methanol. Next
cells were washed in 1X PBS and then blocked in 1X PBS + 1% BSA for 30 minutes at
room temperature. Each sample was subjected to the primary antibody, 4F8 (1:500
dilution in 1X PBS + 1% BSA), for 1 hour at room temperature. After 3 washes with 1X
PBS, samples were incubated with the secondary antibody, 488 anti-mouse (1:1000 in 1X
PBS + 1% BSA), and Dolichos lectin (1:100 in 1X PBS + 1% BSA) for 1 hour at room
temperature. Finally, samples were washed with 1X PBS, rinsed in distilled water and
mounted on a coverslip with Fluoromount-G.
Quantitative RT-PCR.
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qRT-PCR, TaqMan, was performed according to the manufacturer (Qiagen). The
following primers and probes were used: B41-forward: 5’
TGCACACTAAGGCGTACATCAAT 3’, B41-reverse: 5’
TGACAGGAGGCGCACAGTT 3’, B41-probe: 5’
[DFAM]CAGCTGAGTCGCCGTCGAAACG[DBH1] 3’.
Overexpression of EST 13803210

The following primers were used to contruct the alpha-tubulin promoter-EST plasmid:
BamHI-forward: 5’ ATTCGCGGATCCAAAATGCCTGCGGTCTATTGCC 3’, AvrIIreverse: 5’ CTCTTACCTAGGAGCGGGGGTGAAGAGGGAAG 3’, NotI-reverse: 5’
TTTTCCTTTTGCGGCCGCCTTCAGTCCAGACTTTAGGC 3’. The template used
was cDNA EST13803210 (~1.0kb) and genomic DNA EST13803210 (~2.2kb). Parasites
were transfected, subjected to bradyzoite induction conditions and immunofluorescence
assay of bradyzoite-markers were performed.
RACE

The following primers were used for 5’ and 3’ RACE: B41-GSP2: 5’
CCGGGTGTCTTCATCTGTTCGTACTTTG 3’, B41-GSP1: 5’
GACGGCACTGTAATGTATTTGGGTCCAC 3’, B41-NGSP2: 5’
CGATCTGTGTCACTTTGTAGACGCCAAG 3’, B41-NGSP1: 5’
CTGAAATGGCCCACGGCATTTGAAC 3’, B41-GSP3: 5’
TATCAGAAACTGCTCGAGGATCG 3’(to move further towards the 5’ end of gene),
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B41-GSP4: 5’ ATCGATCGATCCAGACGTTC 3’(to get additional sequence at 3’ end
of shorter transcript), B41-GSP5: 5’ ATGTCTCCTGGGGACTGCGTTCTCG 3’(to get
additional sequence at 3’ end of larger transcript).
Cosmid complementation.

Each transfection was performed with 40μg of DNA and stable transgenic lines were
selected with phleomycin (D. Sibley protocol)
3.4 Discussion

Bradyzoite differentiation mutant B7 has been disrupted in a putative ncRNA,
B41. B41 is a large, alternatively polyadenylated, ncRNA that is developmentally
regulated. Overexpression of EST 13803210 does not cause the mutant phenotype
therefore, this EST is not a key player in bradyzoite formation. Unfortunately we were
unable to elucidate the function of B41 since luciferase reporter assays used to test if B41
regulated the EST 13803210 proved to be negative and other attempts towards
elucidation have been technically difficult (data not shown, P. Lescault). However,
several lines of evidence point to B41 as being the gene responsible for the mutant
phenotype; B41 is physically disrupted by the insertion, B41 is the only gene within
100kb of the insertion that has its expression affected in the mutant, and a cosmid
containing B41 complemented mutant B7.
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CHAPTER 4: EPILOGUE

4.2 The new experimental design

Our current data, along with the Roos laboratory’s time course, suggests that wild
type parasites grown under bradyzoite induction conditions (low CO2) for 24h are ‘true’
intracellular tachyzoites, ie., show the same expression profile as wild type parasites
grown under tachyzoite growth conditions (high CO2) (Figure 28).

Figure 28. Clustering of early genes show how our 24h time point (intracellular low
CO2 parasites) express the same as the Roos lab time 0h (intracellular parasites 24h
post invasion).

The first aim of the new experimental design is to validate this result by performing
microarray analysis on wild type parasites grown under high and low CO2 conditions for
24h and then to compare the data for similarities/differences. Our current data also
suggests that 5/7 mutant parasite lines (B7 family), harvested in the extracellular state
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under high (‘freshly’ egressed “t = 0h”) and low (72h post induction) CO2, show similar
expression profiles to wild type intracellular tachyzoites, while 2/7 extracellular mutant
parasite lines (13P family) only show this similarity under low CO2 (72h post induction)
and behave like wild type under high CO2 (‘freshly’ egressed “t = 0h”). Given that the
harvest time point of ‘freshly’ egressed (under high CO2) could have taken place over a
range of time (anywhere up to ~10h), unlike a specific time point such as 72h post
induction, we will perform microarray analysis on a time course of egress under high
CO2. This latter aim serves to rule out that our observation (extracellular mutants behave
like intracellular wild type) is not just due to variable time in harvest at t = 0h. Perhaps,
mutant parasites were harvested at a time when they were visibly extracellular but had
not had enough time to ‘recognize’ that they were outside of the host and, thus, still
expressed a similar profile to intracellular parasites. Whereas, wild type extracellular
parasites had been egressed at such a time during egress where they do recognize that
they are outside of the host and, thus, do express the profile of an extracellular parasite.
The new experimental design required to validate the inferences made in our
current microarray analysis study, will consist of the following parameters:

Number of microarray chips: 8
Parasite lines: (3); wild type-parental RH 7-1, Mutant B7 (to represent the ‘B7 family’;
B7, 11K, 11P, 7K and P11), and Mutant 13P (to represent the ‘13P family’; 13P and
12K)
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Harvest timepoints:
·

Wild type:
o High CO2- 24h- intracellular
o Low CO2- 24h intracellular
o High CO2- 0h- ‘freshly’ egressed
o High CO2- 0+8h- ‘completely’ egressed

·

Mutant B7:
o High CO2- 0h- 'freshly' egressed.
o High CO2- 0+8h- 'completely egressed.

·

Mutant 13P:
o High CO2- 0h- 'freshly' egressed.
o High CO2- 0+8h- 'completely' egressed.

4.2.1 Confirmation that intracellular parasites grown under low CO2 for 24h
represent ‘true’ intracellular tachyzoites (grown under high CO2 for 24h)

We will perform microarray analysis on the following samples; High CO2- 24hintracellular and Low CO2- 24h- intracellular. We hypothesize that these two samples
are similar and if we obtain this result then we can extrapolate the following;
ET.High/LowCO2(B7) = IT.HighCO2(WT) and ET.LowCO2(13P) = IT.HighCO2(WT).
However, if we observe that wild type intracellular parasites grown under high CO2 (24h)
are different from wild type parasites grown under low CO2 (24h) then we will simply
state that ET.High/LowCO2(B7) = IT.LowCO2(WT) and ET.LowCO2(13P) =
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IT.LowCO2(WT). It is not immediately clear to me how this alternative result could be
biologically relevant but nonetheless, it is a clear observation.
4.2.2 Confirmation that extracellular mutants behave like wild type intracellular
tachyzoites

(1) Confirmation of results for the mutant B7 family.
We hypothesize that our observation that ET.HighCO2(B7) ≠ ET.HighCO2(WT)
is independent of time after egress (within the doubling time of a parasite). In order to
confirm our hypothesis about the mutant B7 family, we will perform microarray analysis
on the following samples:
(WT)High CO2- 0h- 'freshly' egressed(A)
(WT)High CO2- 0+8h- 'completely' egressed(B)
(B7)High CO2- 0h- 'freshly' egressed(C)
(B7)High CO2- 0+8h- 'completely' egressed(D)
Our hypothesis states that the comparison of these four samples will yield the following:
o A≠C
o A≠D
o B≠C
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o B≠D
It is completely irrelevant if A = or ≠ B and if C = or ≠D.
However, if we observe the following result, A = C and/or D or B = C and/or D,
then our alternative hypothesis would be that under high CO2 mutant B7 behaves like WT
in a time-after-egress dependent manner. If this is the case then we have now shown that
our previous result (extracellular B7 and WT are different under HighCO2) was an
'artifact' due to inadequate control of the 'egressed' timepoint.
(2) Confirmation of results for the mutant 13P family.
The 13P family of mutant behave like extracellular wild type parasites under high
CO2 but look like intracellular tachyzoites under low CO2 (72h post induction). In this
set of experiments, we want to show how the mutant 13P family are distinct from the
mutant B7 family with respect to our previous results (5/7 mutants (B7 family) behave
like this: ET.High/LowCO2(MUT) ≠ ET.HighCO2(WT); 2/7 mutants (13P family) look
like this: ET.HighCO2(MUT) = ET.HighCO2(WT), but ET.LowCO2(MUT) ≠
ET.HighCO2(WT)). In order to confirm this results we will perform microarray analysis
on the following samples:
(WT)High CO2- 0h- 'freshly' egressed(A)
(WT)High CO2- 0+8h- 'completely' egressed(B)
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(13P)High CO2- 0h- 'freshly' egressed(E)
(13P)High CO2- 0+8h- 'completely' egressed(F)
We hypothesize that the comparison of these four samples will yield the following:
A = E and/or F
B = E and/or F
Again, it is completely irrelevant if A = or ≠ B and if E = or ≠F.
4.3 Specification Reports for interesting genes and gene sets.

During our microarray analysis, we spent a good amount of time thinking about
what types of analyses would best describe the attributes of a given gene or set of genes
of interest. The idea was that we wanted to create the ultimate ‘standardized’ report that
would be informative and clear to the researcher and then we could systematically
reproduce this report for any given gene in an efficient manner. One such report that we
came up with consisted of 4 main analyses; DE plots, Box and Whisker plots, Principle
Components Analysis and an Expression Values/Annotation Table. Each of these
analyses has its own set of parameters that must be defined and once the program is
written it can be used over and over again to produce a standardized report for any given
gene or set of genes. The beauty of producing these reports in this manner is that the
only unique input needed for each report consists of the gene or genes of interest for that
given report and then all of the analysis is automatic. With this reporting mechanism we
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can produce a spec report for any given gene or gene set in a matter of minutes allowing
for a more efficient way to analyze and interpret the microarray data, which is needed
when you are trying to trudge your way through an enormous amount of information.
DE plots are useful for illuminating the overall ‘big picture’ features for all genes
between two samples and seem to be what most people are well acquainted with. The
reason why a DE plot would contribute to the report is because we can highlight the gene
or set of genes of interest on the plot so that it stands out among all other genes and the
researcher will be able to interpret how their favorite gene or set of genes compares to the
rest of the genes for any two samples. The comparison of samples may include any
combination of the following; wild type vs. mutant, mutant-1 vs. mutant-2, wild type vs.
all mutants, replicate-1 vs. replicate-2 and so on. Box and Whisker plots are useful for
detecting patterns of gene expression across samples. In this analysis it may be
informative to know where your favorite gene lies along the box and whisker of a given
sample or set of samples. It may also be useful to look at the pattern(s) of expression for
a given set of genes and see how the pattern changes/remains the same across samples.
Principle Components Analyisis (PCA) is a statistical method that finds patterns among
samples given data of high dimension. For example, in our current microarray analysis,
we had 55 samples (including replicates) and ~8000 gene expression values for each
sample; data of high dimension. For this example, PCA will take into account the level
of variation in expression across all samples (55 components) and then plot the samples
using the top two components that consist of the most variation. In short, the PCA plot is
useful for visualizing which samples behave most like each other (in close proximity to
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each other on the plot) and most different from each other (further away from each other
on the plot). Additionally, PCA can illuminate a trend or pathway of gene expression
from one to sample to the next as in a time course. Finally, the usefulness of the
Expression Value/Annotation Table is to be able to connect how your favorite gene is
behaving in the context of biology (the annotation consisting of gene name, gene
ontology terms, etc.). In conclusion, I think that the design and implementation of the
specification report is an extremely useful tool for expediting analysis and interpretation
and I am grateful that I had the opportunity to work through the thought process involved
in creating such an ‘ultimate’ standardized reporting mechanism.
4.4 Addressing the human RNA contamination concern

Since Toxoplasma gondii are obligate intracellular parasites we will undoubtedly
have human (host cell) RNA contamination in our RNA preparations. There are two
reasons why we can rule out that human contamination affected our data: (1)
bioinformatics were used to access every human probe considered to be put on the
Toxochip before it was put onto the microarray chip to make sure that there would be no
cross hybridization and (2) we ran microarray analysis on two biological replicates of
wild type bradyzoite samples that had 50% human contamination (according to the RNA
Chip assessment comparing human and Toxoplasma ribosomal RNAs) and the probe set
intensities for these chips were comparable to the intensities of chips that had very little
(<5%) human contamination.
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4.5 The B41 gene sequence and open reading frame predictions are similar
between Type I, Type II, and Type III strains of Toxoplasma gondii.

We hypothesize that B41 is a noncoding RNA because it has no substantial open
reading frame (ORF) but is transcribed. It is nonetheless possible that B41 encodes for a
small protein. B41 has several small ORFs (~3amino acids (aa) - 85aa) that are defined
by a nucleotide sequence in any of the six reading frames that has a 5’ end ATG
nucleotide triplet and a 3’ end stop codon (Figure 29).

Figure 29. The small open reading frames predicted for the six reading frames of
the B41 gene.

Computational analysis might allow us to quantitatively support or reject our hypothesis
that B41 is a noncoding RNA, but the amount of information available is likely
inadequate for a definitive conclusion. This type of analysis would involve the prior
probability that an expressed gene is protein coding as well as the conditional
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probabilities of having a maximum ORF length of 85aa in each of the protein coding and
non-protein coding genes. This would allow us to quantify, for example, the extent to
which a maximum ORF of length 85aa provides evidence against a protein product, but
would likely not rule out a small protein product. The computational analysis would also
include analysis of the B41 sequence variation among the three strains. For example, if
the ORF was expressed as a protein then we would expect to observe more selection
against non-synonymous changes than synonymous changes, which should have
relatively less effect on protein function.
We analyzed the primary DNA sequence of the B41 gene across the three major
strains (Figure 30) and found that type II and type III are identical.

Figure 30. Comparison of nucleotide sequence reveals that types II and III are
identical to each other and slightly different from type I.

However, there are 24 single nucleotide changes within the B41 gene for type I compared
to types II /III and these changes account for a 1% identity difference. Interestingly, the
single nucleotide changes do not fall within the longest (85aa) ORF and so would not
affect that ORF if it were real. We can calculate the probability for the 24 nucleotide
changes to occur outside of the 85aa ORF under the null hypothesis;
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p = (1 - ((85)(3)base pairs/2600base pairs))24 = 0.08, which is >0.05.
This result means that we cannot reject the possibility that chance accounts for the
observation that none of the 24 nucleotide changes occurred in the 85aa ORF.
In conclusion, we expect that computational analysis would not be sufficient to
quantitatively support or reject our hypothesis that B41 is a non-protein coding gene and
feel that laboratory experiments (such as mass spectroscopy) would have to be performed
in order to determine whether small proteins are expressed from the B41 gene.
4.6 Future Directions for studying the bradyzoite differentiation mutants
4.6.1 Promoter motif search: looking for common motifs in functionally similar coexpressed gene sets.

Microarray analysis of wild type parasites reveals distinct subsets of genes that
are co-expressed at different time points during the tachyzoite to bradyzoite transition. I
would like to examine the promoter regions of the co-expressed genes to see if I could
identify similar motifs that may contribute to the mechanism by which they are coexpressed. It is interesting to me that the Toxoplasma gondii genome does not contain
traditional transcription factors or their corresponding motifs. For example, the
Toxoplasma gondii genome does contain a gene that has strong homology to the TATA-

binding protein, yet there are no obvious TATA box motifs. It would be of great interest
to figure out what types of mechanisms Toxoplasma gondii uses to control its gene
expression. Given that we now have 3 distinct subsets of genes that are co-expressed, we
should be able to break up each subset into groups with common function and then to
align the promoters (2000bp upstream of the translation start site in attempts to capture
81

the entire promoter) and look for consensus sequences that have significant similarity. I
would venture to guess that the consensus sequence(s) that we find with one subset of coexpressed genes would be different from the consensus sequence(s) we find in the other
subset of co-expressed genes and that those differences may account for the difference in
timing and/or extent of expression during the tachyzoite to bradyzoite transition. One
other way to show that the similarities in sequences within one subset of co-expressed
genes is quite different compared to the similarities in sequences seen in another subset of
co-regulated genes would be to make a phylogenetic tree of the promoters from both
families (two distinct subsets of co-expressed genes) and look for the segregation of
promoters based on common features.
4.6.2 Taking a closer look at the expression pattern across entire chromosomes.

Preliminary analysis of the expression profiles of wild type compared to mutant
B7 across entire chromosomes revealed something quite interesting. There are several
chromosomes that show a distinct pattern of expression across the entire chromosome.
An example of this pattern is shown in Figure 31 (below).

82

Figure 31. Example of what seems to be an unusally non-random pattern of
expression across an entire chromosome.

This non-random pattern of expression across the entire chromosome could have
important implications for how Toxoplasma gondii regulates it gene expression during
the bradyzoite differentiation process.
4.4.3 Analysis of genes with a high R score.

Our microarray analysis of the seven bradyzoite differentiation mutants compared
to wild type allowed us to identify genes that showed the highest variation in expression
levels among all samples. It would be interesting to follow up on these genes and to
figure out how they might be involved in the differentiation process. For example, one
83

gene that has the highest R score is a hypothetical gene (551.m00236) and is exclusively
overexpressed in mutant 7K compared to all other mutants. One experiment that may
give us more insight into whether or not this gene is a key player in bradyzoite formation
would be to overexpress this hypothetical gene in wild type parasites and then induce the
transgenic line to form bradyzoites. It would be interesting if overexpression of this gene
caused the mutant phenotype. It may also be useful to search through the top ~100 genes
that have the highest R scores and look to see if there is a subset of genes that are highly
expressed in mutant 7K (or your favorite mutant) compared to all samples and take a
closer look into those genes. I think the R Score analysis is going to prove to be a very
useful tool for further study of our bradyzoite differentiation mutants that we have at
hand (12K, 13P, B7, 11K, 11P, 7K and P11).
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